Whole Exome Sequencing Market Size, Share, Growth, Forecast 2032

Whole Exome Sequencing Market Insights

According to a report from Zion Market Research, the global Whole Exome Sequencing Market was valued at USD 2.05 Billion in 2023 and is projected to hit USD 8.82 Billion by 2032, with a compound annual growth rate (CAGR) of 17.6% during the forecast period 2024-2032.

This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Whole Exome Sequencing industry over the next decade.

Request Free Sample

The report analyzes the global whole exome sequencing market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the whole exome sequencing industry.

Global Whole Exome Sequencing Market: Overview

Whole exome sequencing is a technology that causes a complete DNA sequence of any organism’s genome at a single time through the help of various laboratory processes. In the future of personalized medicine, the whole genome sequence will play an important role in guiding the therapeutic intervention. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s disease.

Global Whole Exome Sequencing Market: Growth Factors

Cost-effectiveness with the whole exome sequencing as compared with whole-genome sequencing along with global alliances among key research facilities are some of the factors that increase the demand of the global whole exome sequencing market. Apart from this, the increasing population along with rising incidences of cancer and other infectious diseases are also boosting the growth of the global market.

In addition, high investments by companies, both new and old, are on R&D facilities in this technology is also impacting the growth of the market in a positive way. However, lack of skilled manpower and professionals and dependency on the government authorities for approvals and grants are the factors restraining the growth of the market.

Request Free Sample

Global Whole Exome Sequencing Market: Segmentation

On the basis of technology, the global whole exome sequencing market is segmented as sequencing by synthesis, sequencing by ion semiconductor, and others.

Based on the products, the market is segmented as sequencing instruments, sequencing services, kits, data analysis services, and others. Sequencing kits are segmented into end repair, DNA fragmentation, A-Tailing and size selection, target enrichment kit and library preparation kits.

On the basis of applications, the global market is classified into personalized medicine, diagnostics, agriculture and animal research, drug discovery and development, and others.

Based on the end-users segment, the market is divided further into pharmaceutical and biotechnology companies, hospitals and clinics, research centers, academic and government institutions, and others.

Whole Exome Sequencing Market: Report Scope

Global Whole Exome Sequencing Market: Regional Analysis

Based on regions, the global Whole Exome Sequencing market can be divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is the largest market for whole exome sequencing owing to scientific awareness, advanced technology, sufficient funds available at disposal, and the interest of the government and private organizations in developing this method and making it more cost-effective. This trend is followed by Europe and Asia. Asia is anticipated to grow at a considerable rate in the near future.

Request Free Sample

Regular government funding and a large number of conferences on the subject of whole exome sequencing technology and methods are a few of the major factors boosting the growth of the market in this region.

Whole Exome Sequencing Market: Competitive Analysis

The global Whole Exome Sequencing market is dominated by players like:

• BGI
• Ambry Genetics
• Eurofins Genomics, Inc
• Life Technologies
• Illumina, Inc
• GENEWIZ, Inc
• Roche NimbleGen, Inc
• Agilent Technologies
• Knome, Inc.
• Macrogen, Inc

The global Whole Exome Sequencing market is segmented as follows:

By Product

• Sequencing instruments
• Sequencing services
• Kits
• Data analysis services
• Others

By Application

• Personalized medicine
• Diagnostics
• Agriculture and animal research
• Drug discovery and development
• Others

By End User

• Pharmaceutical and biotechnology companies
• Hospitals and Clinics
• Research centers
• Academic and government institutions
• Others

By Technology

• Sequencing by synthesis
• Sequencing by ion semiconductor
• Others

Whole Exome Sequencing Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa